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ABSTRACT 
Thiazolopyrimidine 2 was obtained from the reaction of dihydropyrimidinone with chloroacetic acid and benzaldehyde. 
Thiazolopyrimidine 2 containing an α,β-unsaturated ketonic function [-CH=CH-CO-] has been used as a component of 
Michael addition with an equimolar amount of dinucleophiles to give a series of novel tetracyclic pyrimidine derivatives. 
Treatment of thiazolopyrimidine 2 with uracil, aminotriazole, cyanoacetic acid hydrazide, o-phenylenediamine or 
diaminopyridine afforded the corresponding pyridopyrimidine, triazolopyrimidine, pyrazolone, benzodiazepine and 
triazepine derivative, respectively. The detailed synthesis, spectroscopic data, and antitumor activity for synthesized 
compounds were reported. 
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INTRODUCTION  
α,β-Unsaturated ketones are versatile and convenient intermediates for the synthesis of a wide variety of 
heterocyclic compounds. The α,β-enone moiety of the molecule is a favorable unit for dipolar cycloaddition with numerous 
reagents providing heterocyclic compounds of different ring sizes with one or several heteroatoms. Their reactions with 
dinucleophiles usually result in the formation of polycyclic ring systems which may be the skeleton of important 
heterocyclic compounds [1-5]. Moreover, dihydropyrimidinones 1 (DHPMs, Biginelli compounds) appear to be a class of 
privileged organic compounds with medicinal significance due to their different biological and therapeutic activities [6]. In 
view of these reports and in continuation of our work on biologically active nitrogen and sulfur heterocycles [7-10], we have 
synthesized some new pyrimidine derivatives and tested their antitumor activity. 
 
RESULTS AND DISCUSSION  
In the present work we report the synthesis of several thiazolopyrimidine derivatives based on ethyl 2-
benzylidene-7-methyl-3-oxo-5-phenyl-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate (2) [11], which was 
prepared from ethyl 2-mercaprto-4-methyl-6-phenyl-1,6-dihydropyrimidine-5-carboxylate (1) [12], as starting material. 
Reaction of arylidene derivative 2 with aminotriazole as potential precursor for the synthesis of tetacyclic system was 
investigated. Thus, compound 2 was refluxed with aminotriazole in ethanol containing a catalytic amount of piperidine to 
afford the corresponding triazole derivative 3. The formation of compound 3 is assumed to take place via a Michael type 
addition of NH2 function group of triazole to the activated ethylenic double bond [13], of compound 2 to form the non-
isolable intermediate which readily undergo intramolecular cyclization followed by loss of water molecule to form the target 
compound 3 (Scheme 1). 
 Further, annulation of compound 2 with an uracil moiety fused to C
2
-C
3
 of the pyridine ring was achieved, 
through alkylation of 6-amino-1,3-dimethyluracil with thiazolopyrimidine 2. The problem of C and N-alkylation of enamines 
has been investigated by Troschutz et al. [14], who revealed that the β-carbon center is more nucleophilic than the amino 
group. No attention has been paid to the similar reaction with 6-amino-1,3-dimethyluracil, which can be used as a key 
intermediate for the building of a pyridopyrimidine moiety fused with the thiazolopyrimidine system. Thus, reaction of 
compound 2 with 6-amino-1,3-dimethyluracil in presence of glacial acetic acid gave the adduct 4, through formation of  the 
nonisolable intermediate which underwent intramolecular cyclization through elimination of water molecule to afford the 
final product 4 (Scheme 1).  
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Scheme 1. Synthetic pathway for the formation of triazole 3 and pyridine 4. 
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The 
1
H NMR spectrum of compound 3 revealed a triplet signal at δ 1.07 ppm (J 6.9 Hz) due to CH3 protons, a 
quartet signal at δ 4.02 ppm (J 6.9 Hz) due to CH2 protons, two signals at δ 5.75 and 6.04 due to CH-9, CH-4 protons, 
respectively. It showed also D2O-exchangeable signal at δ 7.61 ppm corresponding to NH proton, in addition to an 
aromatic multiplet in the region 7.28-7.78 ppm. The mass spectrum of compound 3 showed the molecular ion peak at m/z 
470 which is coincident with the molecular weight (470.54) as supports the identity of the structure. While, the 
1
H NMR 
spectrum of compound 4 showed signals at δ 2.28, 3.36 and 3.54 ppm assigned to the three CH3 groups. It showed also 
D2O-exchangeable signal at δ 12.33 ppm corresponding to NH proton, in addition to an aromatic multiplet in the region δ 
6.87-8.12 ppm. The mass spectrum of compound 4 revealed the molecular ion peak at m/z 541 corresponding to the 
molecular formula C29H27N5O4S, which agree well with the molecular weight (541.62) and supports the identity of the 
structure.  
Furthermore, the reaction of α,β-unsaturated ketone with cyanoacetic acid hydrazide in the presence of a base 
gave pyrazolone derivative. Thus, reaction of compound 2 with cyanoacetic acid hydrazide in ethanol containing a 
catalytic amount of piperidine gave pyrazolone derivative 5 (Scheme 2). 
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Scheme 2. Synthetic pathway for the formation of pyrazolone 5. 
The mechanism of formation of pyrazolone 5 involves a cyclocondensation reaction, which is depict in Scheme 3. 
The reaction proceeds by a Michael addition/elimination on the -carbon atom of the enone [15], by the more nucleophilic 
function of the cyanoacetic acid hydrazide [16]. The intermediate formed undergoes cyclization by the addition of NH2 
function to the cyano group to provide enaminoketone intermediate which followed by loss of water molecule to form the 
target compound 5.  
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Scheme 3. The proposed mechanism for the formation of pyrazolone 5. 
 The IR spectrum of compound 5 revealed absorption bands at 1711 and 1680 cm
-1
 corresponding to two C=O groups. Its
 
1
H NMR spectrum revealed a triplet signal at δ 1.12 ppm (J 7.2 Hz) due to CH3 protons, a quartet signal at δ 4.08 ppm (J 
7.2 Hz) due to CH2 protons. It showed also two D2O-exchangeable signals at δ 9.70 and 10.35 ppm assigned to two NH 
protons, in addition to an aromatic multiplet in the region 6.82-7.63 ppm. The mass spectrum of compound 5 showed the 
molecular ion peak at m/z 485 corresponding to the molecular formula C26H23N5O3S. 
Moreover, the reaction of aromatic or heteroaromatic 1,2-diamines with α,-unsaturated ketones is a useful 
method for the preparation of condensed 1,4-diazepine systems [17]. Thus, reaction of 1,2-diamines with α,-unsaturated 
ketones gave different products depending on the experimental conditions. Thiazolopyrimidine  2 was reacted with o-
phenylenediamine in refluxing glacial acetic acid affording the corresponding diazepine derivative 6. Formation of 
compound 6 is believed to take place by the addition of the diamine on the ethylenic double bond of compound 2 followed 
by interamolecular condensation of the amino group with the carbonyl function affording compound 6 as the final product 
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(Scheme 4). Finally, the chalcone 2 was treated with 1,6-diamino-4-(4-chlorophenyl)-2-oxo-1,2-dihydropyridine-3,5-
dicarbonitrile (7) [18], in dimethylformamide to give triazepine 8. Due to the presence of non-equivalent amino groups at 
the ortho-position, regioisomeric cyclization products could be expected. However, the formation of a single product was 
observed, possibly because of the electronic effect of the nitrogen atom which enhances the nucleophilicity of the amino 
group on N-1 [19]. Therefore, the reaction proceeds initially via a Michael type addition by the more nucleophilic amino 
group (N-NH2) of pyridine 7 to the activated ethylenic double bond of compound 2 to form the non-isolable intermediate 
which followed by ring closure through loss of water molecule to produce the desired product 8 (Scheme 4). The 
structures of compounds 6 and 8 were determined from spectroscopic as well as elemental analytical data.
 
The 
1
H NMR 
spectrum of compound 6 revealed signals at δ 5.58 ppm due to CH-4 proton and two D2O-exchangeable signals at 12.58 
ppm corresponding to two NH protons, in addition to an aromatic multiplet in the region δ 7.00-7.85 ppm, while the 
1
H 
NMR spectrum of compound 8 showed signals at δ 5.67 and 6.04 ppm due to CH-4, CH-13 protons, respectively. It 
showed also D2O-exchangeable signal at δ 8.52 ppm corresponding to two NH protons, in addition to an aromatic 
multiplet in the region δ 7.29-7.79 ppm. 
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Scheme 4. Synthetic pathway for the formation of benzodiazepine 6 and triazepine 8. 
 
Antitumor activity 
The antitumor activity of the newly synthesized compounds was investigated against Ehrlich ascites 
carcinoma  cells (EAC). The antitumor efficacy of the compounds against EAC cell lines was demonstrated compared 
to  doxorubicin. The obtained results revealed that compounds 1  a n d  2  exhibited IC50 values less than the used 
standard drug  (doxorubicin). Diazepine derivative 6 was declared active. Further, compound 3 shows promising cytotoxic 
effect against EAC cell lines. While, compounds 4, 5, and 8 were essentially inactive (Table 1). 
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Table 1. Tumor cell growth inhibition expressed as inhibitory concentration IC50 (IC50 the molar concentration that inhibits 
tumor cell growth to 50%): 
      
Compound 
No. 
IC50 ( µg mL
-1
) 
1 38.8 
2 28.1 
3 48.1 
4 _ 
5 _ 
6 45.2 
8 _ 
Doxorubicin 39.5 
 
EXPERIMENTAL PROCEDURE  
Melting points are uncorrected and were recorded in open capillary tubes on a Stuart SMP3 melting point 
apparatus. Infrared spectra were recorded on FT-IR Bruker Vector 22 spectrophotometer using a KBr wafer technique. 
The
 1
H NMR and 
13
C NMR spectra were recorded in DMSO-d6 or CDCl3 on Gemini spectrometer (300 MHz for 
1
H NMR 
and 75 MHz for 
13
C NMR) and the chemical shift in δ downfield from TMS as an internal standard. Elemental 
microanalyses were performed at the Main Laboratories of the War Chemical. Mass spectra were obtained using gas 
chromatography GCMS qp-2010 plus and on a Schimadzu instrument mass spectrometer (70 eV) at the Cairo University 
Microanalytical Center. Ethyl 2-benzylidene-7-methyl-3-oxo-5-phenyl-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-
carboxylate (2) [11], and ethyl 2-mercaprto-4-methyl-6-phenyl-1,6-dihydropyrimidine-5-carboxylate (1) [12], were prepared 
following the literature procedures. 
Ethyl 4,9-diphenyl-7-methyl-4,9-dihydro-3H-[1,2,4]triazolo[3',4':2'',3'']pyrimido[4'',5'':4',5'][1,3]thiazolo[3,2-a] 
pyrimidine-8-carboxylate (3)  
A mixture of compound 2 (0.404 g, 1 mmol) and 3-aminotriazole (0.084 g, 1 mmol) in EtOH (10 mL) and few 
drops of piperidine is refluxed for 6h. The solid thus obtained is  filtered off and recrystallized from EtOH to give compound 
3 as yellow crystals, yield 68%, mp 147-148 °C. IR spectrum (KBr) νmax/cm
-1
: 3040 (CHarom.), 2990 (CHaliph.), 1715 
(C=Oester);
 1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.07 (t, 3H, J 6.9 Hz, CH2CH3), 2.20 (s, 3H, CH3), 4.02 (q, 2H, J 6.9 
Hz, CH2CH3), 5.75 (s, 1H, pyrimidine-H9), 6.04 (s, 1H, dihydropyrimidine-H4), 7.28-7.78 (m, 11H, Ar-H), 7.61 (s, 1H, D2O-
exchangeable, NH); MS m/z (%): 470 [M]
+
 (9.3), 404 (36.3), 327 (100), 306 (16.1), 271 (40), 228 (35.3), 149 (52.5), 113 
(41); Anal. Calc. for C25H22N6O2S (470.54): C, 63.81; H, 4.71; N, 17.86; S, 6.81. Found: C, 63.80; H, 4.71; N, 17.88; S, 
6.80%. 
Ethyl 1,3-dimethyl-2,4-dioxo-5,10-diphenyl-8-methyl-2,3,4,5,10,12-hexahydro-1H-pyrimido[4',5':2'',3'']pyrido 
[6'',5'':4',5'][1,3]thiazolo[3,2-a]pyrimidne-9-carboxylate (4) 
A solution of compound 2 (0.404 g, 1 mmol) and 6-aminouracil (0.155 g, 1 mmol) in glacial acetic acid (10 mL) is 
refluxed for 10 h. The reaction mixture is cooled, then poured into ice water and basified with ammonia solution. The solid 
obtained is filtered off and recrystallized from MeOH to give compound 4 as brown crystals, yield 72%, mp 156-157 °C. IR 
spectrum (KBr) νmax/cm
-1
: 3027 (CHarom.), 2985 (CHaliph.), 1715 (C=Oester), 1700, 1691 (C=Ouracil);
 1
H NMR spectrum (300 
MHz, DMSO-d6) δ 1.14 (t, 3H, J 7.2 Hz, CH2CH3), 2.28 (s, 3H, CH3), 3.36 (s, 3H, CH3), 3.54 (s, 3H, CH3), 4.04 (q, 2H, J 
7.2 Hz, CH2CH3), 5.24 (s, 1H, pyrimidine-H10), 6.05 (s, 1H, dihydropyridine-H5), 6.87-8.12 (m, 10H, Ar-H), 12.33 (s, 1H, 
D2O-exchangeable, NH); MS m/z (%): 541 [M]
+
 (1.7), 525 (41.9), 450 (100), 327 (85.2), 199 (52.9), 173 (54.6), 131 (92.8), 
103 (70.8); Anal. Calc. for C29H27N5O4S (541.62): C, 64.31; H, 5.02; N, 12.93; S, 5.92. Found: C, 64.32; H, 5.02; N, 12.94; 
S, 5.94%.  
Ethyl 3-oxo-4,9-diphenyl-7-methyl-2,3a,4,9-tetrahydro-11H-pyrazolo[3',4':2'',3'']pyrido[5'',6'':5',4'][1,3]thiazolo[3,2-a] 
pyrimidine-8-carboxylate (5) 
A mixture of compound 2 (0.404 g, 1 mmol) and cyanoacetic acid hydrazide (0.099 g, 1 mmol) in EtOH (10 mL) 
and few drops of piperidine is refluxed for 6h. The solid thus obtained is filtered off and recrystallized from MeOH to give 
compound 5 as brown crystals, yield 63%, mp 211-212 °C. IR spectrum (KBr) νmax/cm
-1
: 3200 (NH), 3030 (CHarom.), 2970 
(CHaliph.), 1711 (C=Oester), 1680 (C=Opyrazolone);
 1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.12 (t, 3H, J 7.2 Hz, CH2CH3), 
2.28 (s, 3H, CH3), 4.08 (q, 2H, J 7.2 Hz, CH2CH3), 5.16 (s, 1H, pyrimidine-H9), 5.50 (d, 1H, pyrazolone-H3a), 6.09 (d, 1H, 
dihydropyridine-H4), 6.82-7.63 (m, 10H, Ar-H), 9.70 (s, 1H, D2O-exchangeable, pyrazolone-NH), 10.35 (s, 1H, D2O-
exchangeable, pyridine-NH); MS m/z (%): 485 [M]
+
 (12.6), 396 (58.2), 307 (46.9), 233 (44), 221 (70.6), 207 (35.5), 167 
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(100), 87 (43.9); Anal. Calc. for C26H23N5O3S (485.55): C, 64.31; H, 4.77; N, 14.42; S, 6.60. Found: C, 64.30; H, 4.77; N, 
14.40; S, 6.62%.   
Ethyl 4,12-diphenyl-2-methyl-4,6,11,12-tetrahydropyrimido[2',1':2,3][1,3]thiazolo[4,5-b][1,5]benzodiazepine-3-
carboxylate (6) 
               A mixture of 2 (0.404 g, 1 mmol) and o-phenylenediamine (0.108 g, 1 mmol) is dissolved in glacial acetic acid (10 
mL). The reaction mixture is heated at reflux for 10 h. After cooling, the reaction mixture is cooled and poured gradually 
onto crushed ice and basified with ammonia solution. The solid obtained is filtered off and recrystallized from MeOH to 
give compound 6 as brown crystals, yield 74%, mp 218-219 °C. IR spectrum (KBr) νmax/cm
-1
: 3196 (NH), 3050 (CHarom.), 
2982, 2937 (CHaliph.), 1715 (C=Oester);
 1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.17 (t, 3H, J 6.3 Hz, CH2CH3), 2.28 (s, 
3H, CH3), 4.01 (q, 2H, J 6.3 Hz,  CH2CH3), 5.58 (s, 1H, pyrimidine-H4), 6.05 (s, 1H, diazepine-H12), 7.00-7.85 (m, 14H, 
Ar-H), 12.58 (s, 2H, D2O-exchangeable, 2NH);
 13
C NMR spectrum (75 MHz, CDCl3) δ 17.5, 39.9, 40.2 (aliphatic), 121.9, 
123.5, 129.2, 129.9, 130.3, 131.6, 132.9, 144.6, 145.2 (aromatic), 167.8 (C=O); MS m/z (%): 495 [M+1]
+
 (12.3), 494 [M]
+
 
(2.4), 460 (36.4), 292 (100), 259 (50.8), 162 (54.5), 103 (40.8), 77 (36); Anal. Calc. for C29H26N4O2S (494.60): C, 70.42; H, 
5.30; N, 11.33; S, 6.48. Found: C, 70.40; H, 5.30; N, 11.34; S, 6.46%.  
Ethyl 8-(4-chlorophenyl)-7,9-dicyano-4,13-diphenyl-2-methyl-10-oxo-4,6,10,13-tetrahydro-12H-pyrido[1,2-b] 
pyrimido[2',1':2,3][1,3]thiazolo[4,5-e][1,2,4]triazepine-3-carboxylate (8)  
A mixture of compound 2 (0.404 g, 1 mmol) and diaminopyridine 7 (0.285 g, 1 mmol) is dissolved in DMF (10 
mL). The reaction mixture is heated at reflux for 10 h. After cooling, the reaction mixture is cooled and poured gradually 
onto crushed ice. The solid obtained is filtered off and recrystallized from EtOH to give compound 8 as brown crystals, 
yield 85%, mp 276-277 °C. IR spectrum (KBr) νmax/cm
-1
: 3190 (NH), 3020 (CHarom.), 2980 (CHaliph.), 2225, 2220 (C≡N), 
1710 (C=Oester), 1653 (C=Opyridone); 
1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.11 (t, 3H, J 6.9 Hz, CH2CH3), 2.38 (s, 3H, 
CH3), 4.04 (q, 2H, J 6 Hz, CH2CH3), 5.67 (s, 1H, pyrimidine-H4), 6.04 (s, 1H, triazepine-H13), 7.29-7.79 (m, 14H, Ar-H); 
8.52 (s, 2H, D2O-exchangeable, 2NH);
 13
C NMR spectrum (75 MHz, CDCl3) δ 13.8, 39.9, 40.2 (aliphatic), 115.2, 116.4 
(C≡N), 127.3, 128.6, 129.3, 129.9, 130.2, 131.6, 132.4, 132.9, 133.3, 134.9, 156.5, 158.2 (aromatic), 164.8, 165.1 (C=O); 
Anal. Calc. for C36H26ClN7O3S (672.15):  C, 64.33; H, 3.90; N, 14.59; S, 4.77. Found: C, 64.34; H, 3.90; N, 14.60; S, 
4.78%. 
CONCLUSIONS  
In summary, the thiazolopyrimidine 2 has proved to be a versatile precursor for the synthesis of tetracyclic pyrimidine 
derivatives. The present investigation offers procedures for the synthesis of the poly-condensed new heterocyclic ring 
systems. These compounds were also screened for their antituomer activity.  
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